Back to results
US 7,459,455 B2Granted
Pyrimidine compounds
AssigneeSmithKline Beecham Corporation
InventorsMui Cheung, Kristen Elizabeth Nailor, Douglas McCord Sammond, James Marvin Veal
Life of this patent
Estimating the term…
Abstract
Pyrimidine derivatives, which are useful as TIE-2 and/or VEGFR-2 inhibitors are described herein. The described invention also includes methods of making such pyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
Claims22
A compound of Formula (I):
- or a salt thereof:
- wherein:
- W is C—R, wherein R is hydrogen, halogen, or cyano;
- J is hydrogen, C1-C4 alkyl, C1-C4 haloalkyl, aralkyl, cyanoalkyl, —(CH2)pC═CH(CH2)tH, —(CH2)pC≡C(CH2)tH, or C3-C7 cycloalkyl;
- p is 1, 2, or 3;
- t is 0 or 1;
- D is
- q is 1, 2, or 3;
- Q1 is hydrogen, halogen, C1-C2 haloalkyl, C1-C2 alkyl, C1-C2 alkoxy, or C1-C2 haloalkoxy;
- Q2 is A1 or A2;
- Q3 is A1 when Q2 is A2 and Q3 is A2 when Q2 is A1;
- wherein
- A1 is hydrogen, halogen, C1-C3 alkyl, C1-C3 haloalkyl, —OR1, and
- A2 is the group defined by -(Z)m-(Z1)-(Z2), wherein
- Z is CH2 and m is 0, 1, 2, or 3, or
- Z is NR2 and m is 0 or 1, or
- Z is O and m is 0 or 1, or
- Z is CH2NR2 and m is 0 or 1;
- Z1 is S(O)2, S(O), or C(O);
- and
- Z2 is C1-C4 alkyl, cycloalkyl, heterocyclyl, NR3R4, aryl, arylamino, aralkyl, aralkoxy, or heteroaryl;
- R2, R3, and R4 are each independently selected from hydrogen, hydroxy, alkoxy, aryloxy, aralkoxy, amino, alkylamino, arylamino, aralkylamino, C1-C4 alkyl, C3-C7 cycloalkyl, heterocyclyl, —S(O)2R5, and —C(O)R5;
- R5 is C1-C6 alkyl, or C3-C7 cycloalkyl;
- and
- R6 is the group defined by —(X4)z—(X5), wherein
- X4 is C(H)2 where z is 0, 1, 2, 3, or 4, and
- X5 is hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, alkoxy, haloalkoxy, hydroxy, aryloxy, aralkoxy, halo, CN, —NR7R7, —N(H)C(O)R7, —N(H)C(O)OR7, —N(H)C(O)NR7R7, N(H)S(O)2R7, N(H)S(O)2NR7R7, —OC(O)R7, OC(O)NR7R7, —C(O)R7, —C(O)NR7R7, —SR7, —S(O)R7, S(O)2R7R7, —or S(O)2NR7R7;
- and
- R7 is hydrogen, C1-C6 alkyl, C1-C2 haloalkyl, cycloalkyl, heterocyclyl, alkylamino, alkoxy, aryloxy, aralkoxy, arylamino, aralkylamino, aryl or heteroaryl.
26 more elements
A compound of formula (II):
- or a salt, thereof:
- wherein:
- D is
- q is 1, 2, or 3;
- Q1 is hydrogen, halogen, C1-C2 haloalkyl, C1-C2 alkyl, C1-C2 alkoxy, or C1-C2 haloalkoxy;
- Q2 is A1 or A2;
- Q3 is A1 when Q2 is A2 and Q3 is A2 when Q2 is A1;
- wherein
- A1 is hydrogen, halogen, C1-C3 alkyl, C1-C3 haloalkyl, —OR1, and
- A2 is the group defined by -(Z)m-(Z1)-(Z2), wherein
- Z is CH2 and m is 0, 1, 2, or 3, or
- Z is NR2 and m is 0 or 1, or
- Z is O and m is 0 or 1, or
- Z is CH2NR2 and m is 0 or 1;
- Z1 is S(O)2, S(O), or C(O);
- and
- Z2 is C1-C4 alkyl, cycloalkyl, heterocyclyl, NR3R4, aryl, arylamino, aralkyl, aralkoxy, or heteroaryl;
- R2, R3, and R4 are each independently selected from hydrogen, hydroxy, alkoxy, aryloxy, aralkoxy, amino, alkylamino, arylamino, aralkylamino, C1-C4 alkyl, C3-C7 cycloalkyl, heterocyclyl, —S(O)2R5, and —C(O)R5;
- R5 is C1-C6 alkyl, or C3-C7 cycloalkyl;
- and
- R6 is the group defined by —(X4), —(X5), wherein
- X4 is C(H)2 where z is 0, 1, 2, 3, or 4, and
- X5 is hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, alkoxy, haloalkoxy, hydroxy, aryloxy, aralkoxy, halo, CN, —NR7R7, —N(H)C(O)R7, —N(H)C(O)OR7, —N(H)C(O)NR7R7, N(H)S(O)2R7, N(H)S(O)2NR7R7, —OC(O)R7, OC(O)NR7R7, —C(O)R7, —C(O)NR7R7, —SR7, —S(O)R7, S(O)2R7R7-or S(O)2NR7R7;
- and
- R7 is hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, cycloalkyl, heterocyclyl, alkylamino, alkoxy, aryloxy, aralkoxy, arylamino, aralkylamino, aryl or heteroaryl.
22 more elements
Dependencies are inferred from the claim text.